Guillermo Burillo-PutzeMargarita Alvarez de la RosaEduardo Jesus AguilarEnrique QuinteroAbraham Acevedo-ArozenaJennifer I SempleSergio Luis-LimaJosé A GullónEduardo SalidoIvan Ferraz-AmaroJavier De la TorreVictor MatheuMarta Gonzalez-HernandezMaria LecuonaManuel Hernandez-GuerraRaimundo FreireFederico Díaz-GonzálezJ A Navarro-GonzálvezRicardo López AlmarazA JiménezAlicia Pareja RíosIgnacio Arribas-GarciaM Vanesa Hernández-HernándezJuan LacalzadaE NoriegaI CeballosMario Herrera-PerezJuan Boluda-MengodM Tamayo-JoverAlejandra González-DelgadoJ GutierrezVictoriano Ríos Pérez
P108
Spanish Registry on Spontaneous Coronary Artery DissectionA Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus ErythematosusPETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic LeukemiaExpanded Access Program for Maraviroc At Multiple CentersA Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.GEM05 for Patients With Multiple Myeloma More Than 65 Years OldEfficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal BleedingColorectal Cancer Screening in Familiar-Risk Population: Immunochemical Fecal Occult Blood Testing Versus ColonoscopyTreatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic LeukemiaSildenafil for Secondary Pulmonary Hypertension Due to Valvular DiseaseTreatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 YearsA Study to Observe Vedolizumab Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV SubjectsStudy to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain"Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"Development of Clinical Prediction Rules and Health Services Research in Patients With Heart FailureDesign of a Closed-loop Controller Based on the Bispectral Index (BIS) Effectiveness of the Smith PredictorRestenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring Balloon Pre-dilatation (RIBS VI Scoring)Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCLComparison Colon Capsule Endoscopy vs Optical Colonoscopy for Colorectal Cancer Screening in Familiar-Risk PopulationNeoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast CancerChemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVEValue Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin DEarly Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell LymphomaBendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With RA Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose ChemotherapySafety Profile of Idelalisib in Patients With Refractory Follicular LymphomaProspective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 StudyObservational Study to Confirm Safety and Efficacy of the ROADSAVER Stent for the Treatment of Carotid Artery StenosisLong-Term Follow-up StudyStudy to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell LymphomaA Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast CancerProspective Observational Epidemiologic Study of Maraviroc's SafetyStrategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy RegistryBowel Preparation for Repeat Colonoscopy After Preparation Failure (RepeatPrep Study)
P6153
Evaluating of the Hospital Universitario de Canarias Massive Transfusion ProtocolSafety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular EdemaComparison Colon Capsule Endoscopy vs Optical Colonoscopy for Colorectal Cancer Screening in Familiar-Risk PopulationToothbrushing and Ventilator-associated PneumoniaValue Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin DRisk Factors of Poor Bowel Cleansing in InpatientsClinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With LevosimendanPredictors of Poor Bowel Cleansing and Capsule Endoscopy (CEPREDICT)
P859
Q43710346-6C2B4779-A64B-4039-9327-84B743A6DA6DQ46031966-5373EBC2-1602-447B-AF6C-8E0FAEA929D9Q51934079-EC7C32DB-0DBF-447A-9688-7B59143B7F5EQ54231193-8acc2dd0-4e54-864e-b994-22525fe676e8Q54955194-5609ED2B-AB57-4B5C-BF3C-8D3E3E0EEF29Q56264607-306EEF51-6CB4-4050-ABC4-6A59A06F09D0Q57054159-3DA6BD75-75EC-4CA5-B17E-F52C219402E9Q57320520-0265DA35-2FB8-4B46-8FFB-6CCB57F36DA2Q58327249-73BCD9DA-C342-4544-B8A2-3B60C86A7D94Q58880544-72B2FEFA-1A6B-4AAD-AB50-B77165E3BE87Q59140279-85BA28DA-6370-442A-B5C3-41307B1A9DB4Q59165723-06DD7C45-8C70-423A-8C8B-5546DE71D986Q59706032-1EE87FBE-619B-4DD9-9FD0-2E402495D03EQ60310461-29D3BD8E-B1D1-44D8-B7EC-9E19FBA5A1C4Q64148519-C0354F4F-C758-40BD-A50F-DD853807EC4AQ64167519-F8B471D1-D9F3-47DB-9566-C25CBDFC4847Q67232713-A1706364-34DD-4889-A455-FB57E7DA0933Q73414520-1F8FC02C-7F45-4A67-8BAE-D1DC7ED030E6Q73414520-D0DF41C8-19FD-46E0-B1C4-84AE7F342DEDQ73445905-D0DA2575-4D9C-472B-BE5F-A495487123AEQ73536468-62425DFA-D9C4-40EF-AE78-D31C9C4DFFB1Q77660746-FC420951-DB7E-477E-AF31-FB8A9A505E5AQ80735764-E2BA9248-C420-440B-9496-8B2D4723B3FDQ82479860-61C22CE8-C013-42F0-AC79-DB06B5FCB1D6Q83203290-CAEA9177-8F4D-49F2-8870-6F250153B2A6Q86582039-21C748AE-F969-4F92-807A-C9D7DDD239F0Q86582039-331CF775-2875-4F9E-9DB7-5FAF9F55470DQ86636422-23D8971D-501A-4FBA-98AC-5A977D9742E9Q87706550-E254C5F8-3F46-4571-B153-6B7B6352C962Q87706554-FC297779-6B5A-48D9-B3FF-B3FC821039E3Q89261619-CB188A73-725F-42B7-B773-2D7096065D6AQ89464511-86721BD8-8AA2-4ACD-8CC6-34E6B375AA6DQ89925862-52179D92-695C-45B3-B853-E733787C61DCQ9093471-30d0074a-4dc3-c1ae-e6c6-08c04825ad64
P108
Q61907088-059BFE0E-64A8-4B1D-97B4-9AE2CCA4DDDBQ61909194-64CB602F-D8C2-4047-848B-302C94271314Q61917621-4B519B97-EF9F-464C-AC28-C036F07E345DQ61921417-C3EE52FE-FD1B-49E5-9560-B7D852FF7FE6Q61921655-6DF02D99-25AE-4B9F-9136-5E179859E45BQ61924901-A4036515-A136-42D1-A917-AA6ED755EE6BQ61936693-67EB7887-2238-4BEA-A937-BA2EC9090A42Q61938216-9330F926-1763-48C5-9F3D-507B70D811B0Q61980044-A1A342F1-50DC-416C-9E64-09B43E976E36Q61980068-C11B9410-0873-4705-AEAC-51CFFFB300D8Q61981350-F0FC1DF6-0968-490B-9ECD-49A09D046B5AQ62034766-2D0F0014-9B98-46C1-A629-2CB995B92333Q62042078-ACCF3FEC-FCF2-4536-98E8-A77EBCF8C6CEQ62104815-43C8BEC4-2E13-454C-A178-FEF7B7992024Q62812668-136C8594-636C-406D-BA4A-8A132F19245EQ62812989-8E94B0AA-372F-4040-9BC0-AB80A7A8F178Q62819650-714E39E8-CB2F-46D4-8B71-519D6BB50346Q63228870-0B78B84D-0E53-4314-A8FC-2CCD7B0A8839Q63229215-EAF0304D-4211-4D83-8E15-772C65C01C5CQ63316079-149ED1D7-718C-4BF8-8AEF-B51C341E44D0Q63317937-AA4CC9BF-A218-42F5-9F4C-B530E9939F6FQ63318733-57B314E9-76FE-4AB3-ABE8-87018D74A69AQ63320422-4B2C91C8-1B94-429A-94F5-B36CB69F358AQ63322189-A1A8BBF4-5481-402D-B10D-9FC685CB8B24Q63335238-4A28D390-61DE-4957-9CAC-D9996450CC72Q63339105-2E348595-97C2-4F71-AF0E-6C7886526285Q63340580-2C433230-7019-4CA6-846E-804403D76231Q63340991-577B0560-982F-4594-B763-8843D9A1567BQ63397699-DC898CA5-750D-4CA2-90B1-1B1D8079290CQ63397892-371F9E6D-3665-4A35-A21E-D1C330AEBBE5Q63398014-6381A538-31CB-4C8E-AE10-2872CC4B0134Q63405135-3A4921D5-B165-4091-9A4C-DED24897E634Q63571350-60B50E26-1408-452F-A52C-66E06D47E527Q63571423-FB840314-6BF8-46F8-A7E7-76CECDB4BC68Q63572233-7E107182-ECB7-4231-9941-8171F80EC5ADQ63572991-409EEEB2-9198-4F17-A20D-59764D8CAB79Q63573553-AF9A5DCE-D997-4D3B-BE31-38FF053B1BABQ63573763-F069A030-5CBD-4F37-BF42-99F968EF8C87Q63573813-35E0C725-ADE1-45BE-B3AA-7A3075D714FF
P6153
description
Hospital on Tenerife
@en-gb
Krankenhaus in Spanien
@de
griya sakit
@jv
hospital a Espanya
@ca
hospital em Espanha
@pt
hospital en España
@es
hospital en España
@gl
hospital in Spain
@en
hospital n'España
@ast
hôpital en Espagne
@fr
name
Hospital Universitari de les Canàries
@ca
Hospital Universitario de Canarias (H.U.C)
@es
Hospital Universitario de Canarias
@en
Hospital Universitario de Canarias
@en-gb
Hospital Universitario de Canarias
@it
Hospital Universitario de Canarias
@nl
Hospital Universitario de Canarias
@sv
Hôpital universitaire des Canaries
@fr
type
label
Hospital Universitari de les Canàries
@ca
Hospital Universitario de Canarias (H.U.C)
@es
Hospital Universitario de Canarias
@en
Hospital Universitario de Canarias
@en-gb
Hospital Universitario de Canarias
@it
Hospital Universitario de Canarias
@nl
Hospital Universitario de Canarias
@sv
Hôpital universitaire des Canaries
@fr
altLabel
Canary Islands University Hospital
@en
Canary Islands University Hospital
@en-gb
Hospital universitario de canarias
@es
University Hospital of the Canary Islands
@en
prefLabel
Hospital Universitari de les Canàries
@ca
Hospital Universitario de Canarias (H.U.C)
@es
Hospital Universitario de Canarias
@en
Hospital Universitario de Canarias
@en-gb
Hospital Universitario de Canarias
@it
Hospital Universitario de Canarias
@nl
Hospital Universitario de Canarias
@sv
Hôpital universitaire des Canaries
@fr
P361
P214
P2581
P6366
P950
P1329
+34-922-67-80-61
P17
P213
0000 0000 9826 9219
P214
P2427
grid.411220.4
P2581
P2900
+34-922-65-38-08